Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PHATHOM PHARMACEUTICALS INC.
PHAT | US
10.85
USD0.41
3.93%
PHAT | US
Loading StockChartView...
About PHATHOM PHARMACEUTICALS INC.
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
17/03/2026
Close
10.85
Open
10.44
High
10.94
Low
10.34
Phathom Pharmaceuticals Inc. biopharmaceutical company focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States Europe and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals Inc. was incorporated in 2018 and is headquartered in Florham Park New Jersey.
View LessPHAT | US
Risk
79.8
Sharpe
1.11
Luna's Score
49/100
Recommendation
Hold
Luna says (PHAT | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
What's not Working
Smallcap (300M - 2B USD)
High Short percentage (> 15%)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
55.8%1 month
79.8%3 months
73.1%6 months
63.0%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
25.37
Debt to equity
-2.17
Debt to assets
1.59
Ent. to EBITDA
-2.20
Ent. to rev.
101.64
PEG
-
Other Fundamentals
EBITDA
-252.07M
MarketCap
740.94M
MarketCap(USD)
740.94M
Div. yield
-
Op. margin
-1.06K
Erngs. growth
-
Rev. growth
-
Ret. on equity
-3.49K
Short ratio
15.37
Short perc.
35.61
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
1.83
Range1M
4.37
Range3M
8.29
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.84
Price X volume
10.59M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.20 | 0.53 | Cheaper |
| Ent. to Revenue | 101.64 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 25.37 | 15.55 | Expensive |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 73.11 | 72.80 | Par |
| Debt to Equity | -2.17 | -1.23 | Cheaper |
| Debt to Assets | 1.59 | 0.25 | Expensive |
| Market Cap | 740.94M | 3.66B | Emerging |
